Androgenic Alopecia: Case Study and Treatment Analysis

The 2010 document discussed a case study of a 34-year-old man with Androgenic Alopecia (AGA), a common hair loss condition affecting up to 50% of men by age 50, caused by a genetically determined shortening of the hair growth phase. The study highlighted that AGA is androgen-dependent, with dihydrotestosterone (DHT) causing hair thinning and loss. The genetic factors and inheritance pattern of AGA were not fully understood. The document also explored treatments like Minoxidil and Finasteride. A daily 1 mg dose of finasteride increased hair weight by 21.5% above baseline at 96 weeks, with effects noticeable at 12 weeks. Side effects were minimal. A follow-up study showed a net increase of 46.1% in hair weight for the finasteride group. Other treatments like latanoprost and hair transplantation were also discussed. The study concluded that finasteride and other treatments could effectively treat AGA.